Advertisement

HIV Conference Coverage



How Will Long-Acting HIV Antiretrovirals Work in the Real World?

HIV Activist David Barr on Going Beyond 90-90-90

More from the 90-90-90 Targets Workshop >>




Data Collection Is Revolutionizing HIV Surveillance and Care, but at the Cost of Privacy?

Adherence 2018 Panel Tackles Violence and Its Impact on the HIV Care Continuum

HIV "Providers" Aren't Just Doctors: An Interview With Gerald Friedland, M.D.

More from Adherence 2018 >>




Is Ending the HIV Epidemic Possible, and If So, How?

Is the World Ready for Long-Acting HIV Treatment?

HIVSmart! App Uses Mobile Technology to Link Self-Testing to Care and Counseling

More from CHES 2018 >>




New Study Shows Women's HIV Risk Triples During Pregnancy, Quadruples Postpartum

CDC: Few People Who Could Benefit From PrEP Are Using It

More Women Must Be Included in Academia and in Clinical Trials, Panelists Demand

Separate and Unequal Access Frames Discussion at CROI Panel on U.S. HIV Care Cascade

More from CROI 2018 >>




"Caring at Its Essence": HIV Nurses Recall Pivotal Moments With Patients

Nurse-Led Program Bridges Gap Between HIV Diagnosis and Linkage to Care

In Their Words: Burdens of HIV Nursing Include Lack of Respect and Resources

At ANAC, Nurses Unpack the Importance of Emotional Intimacy in Providing High-Quality Care

More from ANAC 2017 >>




A Review of Late-Stage HIV Antiretroviral Candidates at IDWeek 2017

Ibalizumab Effective Against Drug-Resistant HIV in 48-Week Data

Ignorance About PrEP Is Common Among Health Care Providers, Studies Suggest

PrEP Prescriptions Rise Sharply, but Unequally, in New York City

More from IDWeek 2017 >>




Let's Advance the Conversation Among Black Women on HIV and PrEP

Fighting HIV in the Trump Era: U.S. Advocates Speak Out

Up Close and Personal at USCA: A Day of Action

My Journey Through Health Care and HIV as a Black American

More from USCA 2017 >>




HIV Transmission Despite Adherence to PrEP and No Drug Resistance

Top HIV Researcher Hails a Resurgent Antiretroviral Pipeline

Two-Drug Regimen Shines in HIV Treatment Switch Study

What's Your Message to the Trump Administration About the Fight Against HIV?

More from CROI 2017 >>




No Increased Risk of Liver Cancer After Hepatitis C Treatment With Direct-Acting Antivirals

Spurred by Success of Remote Hepatitis C Care, Program Targets Remote Primary Care

Hepatitis C Research Preview for The Liver Meeting 2016

More from Liver Meeting 2016 >>




What's Hot in HIV Cure Research?

Top Menu Items From the Boiling Cauldron of HIV Clinical Research

HIV Research Preview for IDWeek 2016

More from IDWeek 2016 >>




What Would an HIV Cure Mean for You?

Zero: No Linked HIV Transmissions in PARTNER Study After Couples Had Sex 58,000 Times Without Condoms

Charlize Theron's 8 Quotable Moments About HIV at AIDS 2016

More from AIDS 2016 >>